Boston Partners
CVRS

Boston Partners’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Boston Partners’s Portfolio CVRS Stock Details CVRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-171,256
Closed -$550K – 763
2015
Q4 		$550K Hold
171,256
– – ﹤0.01% 707
2015
Q3 		$529K Buy
+171,256
New +$618K ﹤0.01% 675

Other funds holding CVRS

HPM
HealthCor Partners Management Charleston, South Carolina $50.7M AUM
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GH
GAM Holding Zurich, Switzerland $1.57B AUM 25.73% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Boston Partners's CVRS Position: Q1 2016 in Review

Boston Partners sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q1 2016, closing a stake of 171,256 shares — an estimated $550K sold.

Boston Partners first reported a position in CVRS in Q3 2015 and held it in 2 quarters. The position peaked at $550K in Q4 2015. 37 funds tracked by Wall St. Rank hold CVRS as of Q1 2016.

  • Boston Partners reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q1 2016 after selling out during the quarter.
  • Boston Partners sold 171,256 CORINDUS VASCULAR ROBOTICS, INC shares in Q1 2016, an estimated $550K.
  • Boston Partners first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q3 2015 and held it in 2 quarters.
  • Boston Partners's CORINDUS VASCULAR ROBOTICS, INC position peaked at $550K in Q4 2015.
  • 37 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q1 2016.

Based on Boston Partners's 13F filing for Q1 2016, filed 12 May 2016.